Starpharma Holdings Ltd. (SPHRY)
5.05
-0.80
(-13.68%)
USD |
OTCM |
Oct 02, 16:00
Starpharma Holdings Cash from Operations (TTM) : -2.255M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.255M |
| December 31, 2025 | -0.4056M |
| June 30, 2025 | -4.288M |
| December 31, 2024 | -7.280M |
| June 30, 2024 | -4.592M |
| December 31, 2023 | -4.371M |
| June 30, 2023 | -9.142M |
| December 31, 2022 | -4.638M |
| June 30, 2022 | -9.460M |
| December 31, 2021 | -15.76M |
| June 30, 2021 | -11.42M |
| December 31, 2020 | -7.426M |
| June 30, 2020 | -7.074M |
| December 31, 2019 | -5.563M |
| June 30, 2019 | -7.303M |
| December 31, 2018 | -4.365M |
| June 30, 2018 | -7.863M |
| December 31, 2017 | |
| June 30, 2017 | |
| December 31, 2016 | -14.99M |
| June 30, 2016 | -13.06M |
| December 31, 2015 | -11.60M |
| June 30, 2015 | -10.64M |
| December 31, 2014 | -8.003M |
| June 30, 2014 | -8.975M |
| Date | Value |
|---|---|
| December 31, 2013 | -4.816M |
| June 30, 2013 | -9.925M |
| December 31, 2012 | -16.70M |
| June 30, 2012 | -10.08M |
| December 31, 2011 | -7.162M |
| June 30, 2011 | -6.689M |
| December 31, 2010 | -4.934M |
| June 30, 2010 | -3.195M |
| December 31, 2009 | -2.838M |
| June 30, 2009 | -2.963M |
| December 31, 2008 | -4.216M |
| June 30, 2008 | -4.788M |
| December 31, 2007 | -3.013M |
| June 30, 2007 | -2.653M |
| December 31, 2006 | -4.180M |
| June 30, 2006 | -5.597M |
| December 31, 2005 | -5.899M |
| June 30, 2005 | -4.495M |
| December 31, 2004 | -4.674M |
| June 30, 2004 | -4.287M |
| December 31, 2003 | -3.485M |
| June 30, 2003 | -4.300M |
| December 31, 2002 | -6.482M |
| June 30, 2002 | -3.905M |
| December 31, 2001 | -1.318M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Percheron Therapeutics Ltd. | -3.485M |
| Neuren Pharmaceuticals Ltd. | 6.411M |
| Mayne Pharma Group Ltd. | 10.97M |
| Acrux Ltd. | 0.7159M |
| Zelira Therapeutics Ltd. | -3.113M |